Search
Searching Content indexed under Food and Drugs Law by Khaitan & Co ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Making Markets Work For Affordable Healthcare
Recently, the Competition Commission of India (CCI) released a policy note titled Making Markets Work for Affordable Healthcare (Policy Note).
India
28 Nov 2018
2
Legal Metrology Department Has No Powers To Impose Restrictions On Sale Of Unpackaged Food Items In Cinema Halls, Rules High Court
The Multiplex Association of India and PVR Limited challenged the following two orders issued by the Controller of Legal Metrology, an authority appointed under the Legal Metrology Act, 2009, in Writ Petition No. 27029 ...
India
9 Sep 2018
3
Delhi High Court Promotes Indigenous R&D In The Pharmaceutical Industry: Novel Drug Delivery Systems Are Not Implicitly Included Under The Drugs (Price Control) Order, 2013
In the recent case of Modi-Mundipharma Private Limited v Union of India & Ors., (Writ Petition (Civil) No. 11802 of 2016), the High Court of Delhi has clarified that incremental innovation...
India
8 Aug 2018
4
Evolution Of E-Pharmacies In India – Booming Present, But An Uncertain Future
The e-commerce sector has grown exponentially over the last decade and has revolutionised the interplay between internet and commerce worldwide.
India
18 Jul 2018
5
DTAB Appoints Committee To Review Fixed Dose Combinations
The DTAB has reportedly appointed an expert committee under Ms Nilima Shirsagar, retired dean of Mumbai's KEM Hospital to review the safety, efficacy and therapeutic justification of several fixed dose combinations.
India
20 Feb 2018
6
Supreme Court Permits Hotels & Restaurants To Sell Bottled Water At Prices Higher Than MRP
The apex court has permitted hotels and restaurants to charge prices higher than the Maximum Retail Price (MRP) on bottled water sold to customers as part of food and drinks service.
India
8 Jan 2018
7
Supreme Court Expands Government's Powers To Ban Drugs Under Section 26a Of The Drugs & Cosmetics Act, 1940
On 10 March 2016, the Central Government issued 344 identically worded notifications (Notifications) prohibiting the manufacture, sale and distribution of 344 fixed dose combinations (FDCs).
India
5 Jan 2018
8
Guidelines For Food Recall
The Food Safety and Standards Authority of India (FSSAI) recently released guidelines (Guidelines) on food recall by food business operators (FBO) pursuant to the Food Safety and Standards (Food Recall Procedure) Regulations, 2017, (Regulations).
India
12 Dec 2017
9
The Medical Devices Rules – An Analysis
The healthcare industry in India has seen an impressive growth trajectory in the past few years and the Indian medical devices market has been the sunrise segment in the healthcare space.
India
11 Sep 2017
10
Amendments To The Legal Metrology (Packaged Commodities) Rules, 2011
The purpose of the Legal Metrology (Packaged Commodities) Rules, 2011 (PCR) is to regulate pre-packaged commodities. Under the PCR, pre-packaged commodities must comply with certain mandatory labelling requirements.
India
4 Jul 2017
11
Requirement Of Bio-Equivalence Studies For Generic Drugs – A Step In The Right Direction
Access to affordable and safe medicines is the cornerstone of a vibrant public health framework.
India
26 Apr 2017
12
Delhi High Court Strikes Down Notification Dated 10 March 2016 Issued By The Government Of India Banning 344 Fixed Dose Combination (FDC) Drugs
FDCs are combinations of two or more active pharmaceutical ingredients in fixed ratios, given in the form of a single dose.
India
2 Dec 2016
13
Lee Pharma's Compulsory License Application For Saxagliptin Rejected By Indian Patent Office
In an order dated 19 January 2016 (Order), the Controller General of Patents and Trademarks rejected the application for Compulsory License for the patent covering AstraZeneca's diabetes management drug Saxagliptin.
India
23 Jan 2016
14
Pfizer's Patent Application Relating To Rheumatoid Arthritis Drug (Tofacitinib) Rejected By Indian Patent Office
The Indian Patent Office has passed an order on 3 September 2015 rejecting patent application no. 991/MUMNP/2003 to Pfizer Products, Inc. for rheumatoid arthritis drug ‘Tofacitinib'.
India
10 Sep 2015
15
Compulsory License For Astrazeneca's Diabetes Management Drug Saxagliptin?
In a recent development, a compulsory license (CL) application has been filed for the patent covering AstraZeneca's diabetes management drug Saxagliptin.
India
8 Jul 2015
Links to Result pages
 
1